Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 3 January 1997:
Vol. 275. no. 5296, pp. 73 - 77
DOI: 10.1126/science.275.5296.73

Reports

Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains

Z. Songyang, * A. S. Fanning, C. Fu, J. Xu, S. M. Marfatia, A. H. Chishti, A. Crompton, A. C. Chan, J. M. Anderson, L. C. Cantley

The oriented peptide library technique was used to investigate the peptide-binding specificities of nine PDZ domains. Each PDZ domain selected peptides with hydrophobic residues at the carboxyl terminus. Individual PDZ domains selected unique optimal motifs defined primarily by the carboxyl terminal three to seven residues of the peptides. One family of PDZ domains, including those of the Discs Large protein, selected peptides with the consensus motif Glu-(Ser/Thr)-Xxx-(Val/Ile) (where Xxx represents any amino acid) at the carboxyl terminus. In contrast, another family of PDZ domains, including those of LIN-2, p55, and Tiam-1, selected peptides with hydrophobic or aromatic side chains at the carboxyl terminal three residues. On the basis of crystal structures of the PSD-95-3 PDZ domain, the specificities observed with the peptide library can be rationalized.

Z. Songyang, J. Xu, L. C. Cantley, Division of Signal Transduction, Beth Israel Hospital, and Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
A. S. Fanning and J. M. Anderson, Departments of Internal Medicine and Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA.
C. Fu and A. C. Chan, Howard Hughes Medical Institute, Center for Immunology, Department of Medicine and Pathology, Washington University School of Medicine, St. Louis, MO 63110, USA.
S. M. Marfatia and A. H. Chishti, Laboratory of Tumor Cell Biology, Department of Biomedical Research, St. Elizabeth's Medical Center, Tufts University, Boston, MA 02135, USA.
A. Crompton, ONYX Pharmaceuticals, 3031 Research Drive, Building A, Richmond, CA 94806, USA.
*   To whom correspondence should be addressed. Present address: 68-380, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.


Read the Full Text





ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)